Shortened axi-cel manufacturing drives rapid in vivo expansion and shifts the acute toxicity profile in R/R LBCL.
Overview & Synopsis
Open access biomedical research article published in Blood Adv.
Indexed from repository: PubMed Central
(
pmc.ncbi.nlm.nih.gov)
Keyboard Shortcuts:
← / → for pages • + / - for zoom • 0 to fit width
Powered by Mozilla PDF.js v3.11
Document Information
| Document Title | Shortened axi-cel manufacturing drives rapid in vivo expansion and shifts the acute toxicity profile in R/R LBCL. |
|---|---|
| Author / Organization | Panozzo B, Rubic M, Li J, Cashion C, O'Leary NL, Farina S, Minson AG, Baldwin K, Sartor M, Marzulli T, Gorniak MB, Tam CS, Harrison SJ, Westerman DA, Dickinson MJ, Blyth E, Fleming S, Bishop DC, Dowling MR |
| Subject & Discipline | Blood Adv |
| Categories | Medicine & Health |
| License / Rights | Open Access / Creative Commons |
| Resource Verification | Listed PDF (Verification Pending) |
| Original Host Website |
PubMed Central
(pmc.ncbi.nlm.nih.gov)
|
| File Format | application/pdf (Portable Document Format) |
| Language | EN |
| Catalog ID | DOC-16319 |
| Original Source Link | Visit Source Page on pmc.ncbi.nlm.nih.gov » |